Elevating Rare Disease Patient Care: Leveraging Data, AI, And Digital Innovation For Commercial Success

By Maria Kirsch, President, Patient Services; Scott Snyder, Chief Digital Officer; Faruk Abdullah, President, Professional Services and Chief Business Officer; Pierantonio Russo, MD, FCPP, FAAP, STS, Corporate Chief Medical Officer, EVERSANA

Patients with rare diseases face many barriers on their treatment journey due to their disease’s unique characteristics, diagnostic hurdles, and treatment complexities. The lack of clinical data, research, and specialized expertise add further complexity, and the wide range of symptoms and unpredictable disease trajectories make it challenging to establish standardized diagnostic criteria and develop effective therapies. Navigating the rare disease ecosystem demands collaboration across interdisciplinary fields and innovative approaches.

However, technological advancements hold promise to revolutionize patient outcomes. Artificial Intelligence (AI), innovative data-sharing platforms, Machine Learning (ML), and the rising prevalence of digital healthcare are removing barriers to care for patients with rare diseases and accelerating both the diagnosis of these diseases and the development timelines for life-saving therapies. Examine how the integration of AI, coupled with the immense power of data and ML, has unlocked new avenues for research, diagnosis, and treatment.